ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Armata Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$3.07−0.30 (-8.90%)
Close on Oct 19, 2026
- Market cap
- $190.47M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Armata Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 23, 2026 | Sep 23, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 14, 2026 | Sep 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 20, 2026 | Jul 20, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 17, 2026 | Jul 20, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 13, 2026 | Jul 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2026 | Jun 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 16, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 11, 2026 | Apr 27, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 24, 2026 | Apr 27, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 2, 2026 | Apr 2, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 25, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2026 | Mar 25, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2026 | Mar 19, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 23, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 26, 2026 | Jan 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2026 | Jan 13, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 1, 2025 | Dec 1, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 22, 2025 | Oct 22, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 10, 2025 | Sep 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 19, 2025 | May 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | May 1, 2025 | May 1, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2025 | Apr 28, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 2, 2025 | Apr 2, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 21, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 20, 2025 | Mar 21, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2025 | Mar 12, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2024 | Dec 19, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 2, 2024 | Dec 4, 2024 | SEC EDGAR |